Literature DB >> 1670917

HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance.

M Duvic1, M K Hordinsky, V C Fiedler, W R O'Brien, R Young, J D Reveille.   

Abstract

Because predisposition to autoimmunity has been associated with HLA-D alleles and alopecia areata is hypothesized to be a T-cell mediated autoimmune hair loss, we determined DR and DQ alleles in 88 white and 10 American black patients with alopecia areata as well as controls with the use of restriction fragment length polymorphism typing with cDNA probes. White patients with alopecia areata have an increase in the phenotype frequencies of DR4 and DQw8 and an increase in genotype frequencies of DR4 and DR5 (now DRw11[5]). These associations are in agreement with those reported in two other studies but are not significant when corrected by the number of HLA antigens tested. Sixty-one percent of all patients with AA have DR4 and/or DRw11(5) specificities vs 40% of controls, with more DR4,DRw11(5) and DQw7(w3), DQw8(w3) heterozygotes among patients. DQw6(w1) phenotype frequencies and DRw52a phenotype and genotype frequencies are significantly decreased in patients with alopecia areata relative to controls. This highly significant negative association with the HLA DRB3 allele DRw52a in whites persisted even when DR4- or DRw11(5)-positive individuals were excluded from the patient and control groups. These data suggest that HLA-DR4 and DRw11(5) with their associated DQw7(w3) and DQw8(w3) specificities may confer susceptibility to alopecia areata, while DRw52a may confer resistance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670917

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  7 in total

Review 1.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  HLA antigens in individuals with down syndrome and alopecia areata.

Authors:  Juliany L Estefan; Juliana C Oliveira; Eliane D Abad; Simone B Saintive; Luis Cristóvão Ms Porto; Marcia Ribeiro
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

3.  Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.

Authors:  A Gilhar; Y Ullmann; T Berkutzki; B Assy; R S Kalish
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

4.  Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata.

Authors:  G M Galbraith; J P Pandey
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

Review 5.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

6.  Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study.

Authors:  Hsing-Ying Ho; Chih-Kai Wong; Szu-Yuan Wu; Ray C Hsiao; Yi-Lung Chen; Cheng-Fang Yen
Journal:  Int J Environ Res Public Health       Date:  2021-02-01       Impact factor: 3.390

Review 7.  Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?

Authors:  R Paus; A Slominski; B M Czarnetzki
Journal:  Yale J Biol Med       Date:  1993 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.